ClassID:

94452

C07D235/24 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems; Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Sub-classes:
Recent Application in this class:
#1
20260055063
2026-02-26

COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF

#2
20250205232
2025-06-26

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#3
20240417374
2024-12-19

SMALL MOLECULE ANTAGONIST TO PACAP RECEPTOR AND USES THEREOF

#4
20240285772
2024-08-29

PNICTOGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND THEIR USE

#5
20240140940
2024-05-02

CARBOXYLIC ACID, ACYL SULFONAMIDE AND ACYL SULFAMIDE-DERIVATIZED BICYCLIC AZA-HETEROAROMATICS AS SELECTIVE MCL-1 INHIBITORS AND AS DUAL MCL-1/BCL-2 INHIBITORS

#6
20240083903
2024-03-14

ARYL ETHER COMPOUNDS AS TEAD MODULATORS

#7
20230312511
2023-10-05

Selective D3 dopamine receptor agonists and methods of their use

#8
20230303489
2023-09-28

COMPOUNDS, COMPOSITIONS AND METHODS OF USE

#9
20230295116
2023-09-21

PROTEASOME ENHANCERS AND USES THEREOF

#10
20230271951
2023-08-31

DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS

#11
20230233560
2023-07-27

Modulators of cystic fibrosis transmembrane conductance regulator

#12
20230183182
2023-06-15

COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF

#13
20230142739
2023-05-11

PROTEIN-PROTEIN INTERACTION STABILIZERS

#14
20220304984
2022-09-29

AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF

#15
20220267260
2022-08-25

COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS

#16
20220169581
2022-06-02

DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST

#17
20220064128
2022-03-03

Aminocarbamoyl compounds for the treatment of viral infections

#18
20210323941
2021-10-21

Selective Ddopamine receptor agonists and methods of their use

#19
20210317102
2021-10-14

INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY

#20
20210119138
2021-04-22

Organic electroluminescence device and polycyclic compound for organic electroluminescence device

#21
20210078978
2021-03-18

Benzoimidazoles as prolyl hydroxylase inhibitors

#22
20210078885
2021-03-18

Method for monitoring fluorescent polymer antiscalants in industrial water systems

#23
20210052584
2021-02-25

Modulators of cystic fibrosis transmembrane conductance regulator

#24
20200377457
2020-12-03

MIF MODULATORS

#25
20200299285
2020-09-24

Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitors

#26
20200270211
2020-08-27

Compounds, compositions and methods of use

#27
20200255412
2020-08-13

Imidazolecarboxamides and Their Use as FAAH Inhibitors

#28
20200140395
2020-05-07

1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors

#29
20190367486
2019-12-05

Benzoimidazoles as prolyl hydroxylase inhibitors

#30
20190270706
2019-09-05

MIF modulators

#31
20190269683
2019-09-05

Modulators of cystic fibrosis transmembrane conductance regulator

#32
20190255064
2019-08-22

Benzimidazole derivatives as PI3 kinase inhibitors

#33
20190119264
2019-04-25

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

#34
20180263994
2018-09-20

Benzimidazole derivatives as PI3 kinase inhibitors

#35
20180215732
2018-08-02

BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS

#36
20180185364
2018-07-05

Modulators of cystic fibrosis transmembrane conductance regulator

#37
20180170882
2018-06-21

N-Methylbenzimidazoles as mIDH1 inhibitors

#38
20180162813
2018-06-14

MIF modulators

#39
20180022733
2018-01-25

BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS

#40
20170369448
2017-12-28

Compounds for affinity chromatography and for extending the half-life of a therapeutic agent

#41
20170204066
2017-07-20

Trans-base tunnel reader for sequencing

#42
20170152288
2017-06-01

LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY

#43
20170152268
2017-06-01

Fused heterocyclic ring compounds and method of treating retinal disease using same

#44
20170152249
2017-06-01

Benzimidazole derivatives as kinase inhibitors

#45
20170044100
2017-02-16

INHIBITORS OF DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS

#46
20160355476
2016-12-08

Indole and benzimidazolecarboxamides as insecticides and acaricides

#47
20160333009
2016-11-17

Benzimidazole and imadazopyridine carboximidamide compounds

#48
20160221962
2016-08-04

Compounds for affinity chromatography and for extending the half-life of a therapeutic agent

#49
20160176854
2016-06-23

Imidazolecarboxamides and their use as FAAH inhibitors

#50
20160108002
2016-04-21

UNIVERSAL READER MOLECULE FOR RECOGNITION TUNNELING

#51
20160046602
2016-02-18

Inhibitors of c-fms kinase

#52
20160039750
2016-02-11

Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex

#53
20160009703
2016-01-14

Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof

#54
20150336967
2015-11-26

Benzimidazole derivatives as Kinase Inhibitors

#55
20150289512
2015-10-15

METHOD FOR PROMOTING PLANT GROWTH

#56
20150284335
2015-10-08

Benzoimidazoles as prolyl hydroxylase inhibitors

#57
20150266893
2015-09-24

Fused ring analogues of anti-fibrotic agents

#58
20150252043
2015-09-10

Hematopoietic growth factor mimetic small molecule compounds and their uses

#59
20140378456
2014-12-25

Benzimidazole derivatives as PI3 kinase inhibitors

#60
20140221431
2014-08-07

Histone deacetylase inhibitor of benzamides and use thereof

#61
20140148448
2014-05-29

Inhibitors of c-fms kinase

#62
20140142321
2014-05-22

Benzimidazole derivatives as PI3 kinase inhibitors

#63
20140142147
2014-05-22

Carbocyanines for G-quadruplex DNA stabilization and telomerase inhibition

#64
20140088167
2014-03-27

Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides

#65
20140045903
2014-02-13

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#66
20130338151
2013-12-19

Fused ring analogues of anti-fibrotic agents

#67
20130197221
2013-08-01

Benzimidazole derivatives as PI3 kinase inhibitors

#68
20130131321
2013-05-23

LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY

#69
20130085276
2013-04-04

Carboxylation catalysts

#70
20130040389
2013-02-14

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#71
20130035487
2013-02-07

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#72
20120309794
2012-12-06

COMPOUNDS INHIBITORS OF ENZYME LACTATE DEHYDROGENASE (LDH) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS

#73
20120295904
2012-11-22

Hematopoietic growth factor mimetic small molecule compounds and their uses

#74
20120277238
2012-11-01

PHARMACEUTICAL COMPOSITION CONTAINING FUSED HETERO-RING DERIVATIVE

#75
20120270863
2012-10-25

FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS

#76
20120088767
2012-04-12

Benzimidazole derivatives as P13 kinase inhibitors

#77
20120064032
2012-03-15

Hydroxamates as therapeutic agents

#78
20120046322
2012-02-23

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#79
20120040974
2012-02-16

MIF MODULATORS

#80
20120004261
2012-01-05

MIF modulators

#81
20110306611
2011-12-15

Transcription factor modulating compounds and methods of use thereof

#82
20110301156
2011-12-08

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions

#83
20110230452
2011-09-22

Compounds and methods for the treatment of pain and other diseases

#84
20110223093
2011-09-15

IONIC LIQUID SYSTEMS FOR CARBON DIOXIDE AND SULFUR DIOXIDE REMOVAL

#85
20110144153
2011-06-16

Amide compound

#86
20110105572
2011-05-05

CARBAMIC ACID COMPOUNDS COMPRISING AN AMIDE LINKAGE AS HDAC INHIBITORS

#87
20110046132
2011-02-24

Benzoimidazoles as prolyl hydroxylase inhibitors

#88
20110021528
2011-01-27

Hydroxamates as therapeutic agents

#89
20100311787
2010-12-09

Compounds for inflammation and immune-related uses

#90
20100267714
2010-10-21

MIF modulators

#91
20100249197
2010-09-30

Carbamic acid compounds comprising an amide linkage as HDAC inhibitors

#92
20100234377
2010-09-16

PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE

#93
20100222396
2010-09-02

4-ARYL-BUTANE-1,3-DIAMIDES

#94
20100216746
2010-08-26

Chemical compounds

#95
20100137298
2010-06-03

Biaryl Sulfonamides and Methods for Using Same

#96
20100130737
2010-05-27

Regulating Agent of GPR34 Receptor Function

#97
20100093733
2010-04-15

AMIDE AND UREA DERIVATIVES FOR THE TREATMENT OF METABOLIC DISEASES

#98
20100061928
2010-03-11

LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS

#99
20090318514
2009-12-24

Novel Pharmaceutical Compositions

#100
20090220454
2009-09-03

Hydroxamates as therapeutic agents

#101
20090187015
2009-07-23

Process for preparing substituted benzimidazole compounds

#102
20090156590
2009-06-18

Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions

#103
20090099236
2009-04-16

3-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof

#104
20090048300
2009-02-19

Heterocyclic compounds

#105
20080255221
2008-10-16

Hydroxamates as therapeutic agents

#106
20080255214
2008-10-16

Hydroxamates as therapeutic agents

#107
20080188668
2008-08-07

Process for preparing substituted benzimidazole compounds

#108
20080139547
2008-06-12

ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE

#109
20080064741
2008-03-13

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#110
20080004331
2008-01-03

Hydroxamates as therapeutic agents

#111
20070299070
2007-12-27

2-arylcarboxamide-nitrogenous heterocycle compound

#112
20070293540
2007-12-20

NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS

#113
20070275965
2007-11-29

Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2

#114
20070254912
2007-11-01

Benzimidazolyl-pyridine compounds for inflammation and immune-related uses

#115
20070249661
2007-10-25

Compounds for inflammation and immune-related uses

#116
20070249649
2007-10-25

Inhibitors of C-FMS kinase

#117
20070213379
2007-09-13

Malonamides and malonamide derivatives as modulators of chemokine receptor activity

#118
20070191444
2007-08-16

Benzimidazolyl derivatives

#119
20070123527
2007-05-31

3-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof

#120
20070078184
2007-04-05

Amino alcohol derivatives, medicinal composition containing the same, and use of these

#121
20070021410
2007-01-25

Respiratory syncytial virus replication inhibitors

#122
20060293379
2006-12-28

Quaternary salt CCR2 antagonists

#123
20060160799
2006-07-20

Transcription factor modulating compounds and methods of use thereof

#124
20060154913
2006-07-13

Respiratory syncytial virus replication inhibitors

#125
20060111415
2006-05-25

2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors

#126
20060111414
2006-05-25

2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors

#127
20060111413
2006-05-25

2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors

#128
20060020146
2006-01-26

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#129
20050261211
2005-11-24

Process for preparing substituted benzimidazole compounds

#130
20050239771
2005-10-27

Respiratory syncytial virus replication inhibitors

#131
20050234047
2005-10-20

Respiratory syncytial virus replication inhibitors

#132
20050187261
2005-08-25

Hydroxamates as therapeutic agents

#133
20050171366
2005-08-04

Method of preparing intermediates useful in synthesis of retroviral protease inhibitors

#134
20050154202
2005-07-14

Substituted aryl amides

#135
20050143422
2005-06-30

Biaryl sulfonamides and methods for using same

#136
20050131018
2005-06-16

Acetylene derivatives as inhibitors of histone deacetylase

#137
20050038069
2005-02-17

Substituted azabicyclic compounds

#138
20050009829
2005-01-13

Benzimidazole-derivatives as factor Xa inhibitors